MedPath

Effectiveness of Probiotic Supplement In Improving Attention Deficit Hyperactivity Disorder Symptoms

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Dietary Supplement: Probiotic
Other: Placebo
Registration Number
NCT04333394
Lead Sponsor
National Nutrition and Food Technology Institute
Brief Summary

To study the effects of probiotic supplement in children with Attention-deficit hyperactivity disorder (ADHD),40 patients will be randomly allocated to two groups of intervention and placebo. The intervention and the placebo group will be prescribed with 1 capsule of probiotics and placebo for 8 weeks, respectively. Treatment efficacy will be assessed via administrating the Conners's rating

Detailed Description

Both probiotics and placebo groups will receive medication with Ritalin in a dose-dependent manner, starting at the onset of the study and simultaneous with probiotic supplementation. Children weighed 30 Kg or less receive 0.3 mg/kg of Ritalin in 3 separate intervals and after four weeks the dosage will increase to 0.5mg/kg. Those who weighed more than 30 kg receive 0.5 mg/kg with the same pattern that reaches the highest point of 0.7 mg/kg by week four. Each dosage will be administrated trice a day with breakfast, lunch, and dinner. In the middle of the study patients who consumes less than 80% of their supplements will be omitted from the study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Clinical diagnosis of Attention Deficit Hyperactivity Disorder
  • Having an Intelligence quotient more than 85 based on Wechsler test for children
  • Willing to participate in the study
Exclusion Criteria
  • History of any other mental and psychological disorder such as depression, chronic motor tic disorder, communication disorder, learning disability
  • Taking any stimulant, sedative, anti-anxiety and anti-psychotic medications
  • History of any chronic disorders, requiring long term medication (such as cancers, Cirrhosis, autoimmune disorders, metabolic disorders ) or, chronic neurological disorders (such as epilepsy)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ProbioticProbioticThe probiotics capsules contain 7 strains of friendly bacteria (Lactobacillus casei PXN 37, Lactobacillus rhamnosus PXN 54, Streptococcus thermophilus PXN 66, Bifidobacterium breve PXN 25, Lactobacillus acidophilus PXN 35, Bifidobacterium longum PXN 30, Lactobacillus bulgaricus PXN 39)
PlaceboPlaceboPlacebo capsules have an identical appearance to probiotic capsules and contain microcrystal cellulose.
Primary Outcome Measures
NameTimeMethod
The severity of the Attention-deficit hyperactivity disorder (ADHD)8 weeks

The severity of the ADHD was assessed using the Clinical Global Impression (CGI) test

symptoms of Attention-deficit hyperactivity disorder (ADHD)8 weeks

symptoms were assessed using Conners's scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Nutrition and Food Technology Research Institute

šŸ‡®šŸ‡·

Tehrān, Tehran, Iran, Islamic Republic of

Ā© Copyright 2025. All Rights Reserved by MedPath